Chrissy Metz, known for her role in the hit series This Is Us, recently shared her decision to begin using a GLP-1 medication. The 45-year-old actress admitted that she started with significant skepticism, noting that she initially believed the medication would not work for her personal needs. Over time, however, she noticed a change in how she processed food. She describes the reduction in food noise as a benefit that allows her to focus on her life and career without constant preoccupation with what she consumes.
Beyond the mental clarity, Metz reported physical improvements that have supported her active lifestyle. She highlighted increased mobility and decreased joint pain, which have made performing on Broadway in & Juliet a much more manageable task. She emphasized that she moved away from the mindset of viewing food as a moral failing or something inherently bad. Instead, she now focuses on how her body feels and functions, noting that her recent blood work results show positive trends for her overall health.
Metz also touched on the public reception of her choice. She noted that people often judge her decisions regardless of her actions, but she remains focused on her well-being during perimenopause. She pointed out that her family history of obesity played a role in her decision to seek a medical solution after other traditional methods like dieting and therapy did not yield the results she wanted. She maintains that this is not a magic solution but rather a tool to help her feel capable and strong.
To assist with her care, the actress partnered with the telehealth company Ro. She found the remote access to doctors and the delivery of the medication to her home to be a convenient way to manage her health. Metz insists that she is not striving for a specific number on a scale, but rather a state of being where she feels comfortable in her own skin. She continues to work with a trainer to build muscle, focusing on her long-term health rather than quick fixes.

